Transcriptomic expression levels of the VHL, TIMP-3, and RASSF1A genes in renal tumors

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Renal tumors encompass a range of neoplastic conditions affecting the kidney.
• Understanding the molecular underpinnings of renal tumor development is crucial for diagnosis and treatment.
• Specific gene expression patterns may serve as biomarkers or therapeutic targets.

Purpose of the Study:

• To examine the relationship between messenger RNA (mRNA) expression levels of VHL, TIMP-3, and RASSF1A genes and the clinicopathological features of patients with renal tumors.
• To compare gene expression in cancerous versus non-cancerous renal tissues.

Main Methods:

• Radical nephrectomy specimens from 69 patients with kidney tumors were analyzed.
• Quantitative real-time polymerase chain reaction (qPCR) was employed to measure mRNA expression levels of VHL, TIMP-3, and RASSF1A.
• GAPDH served as the reference gene for normalization.

Main Results:

• VHL gene expression was significantly elevated (2.8-fold) in renal cell carcinoma (RCC) cancerous tissue compared to adjacent non-cancerous tissue (p < 0.05).
• TIMP-3 and RASSF1A mRNA levels showed non-significant increases in RCC cancerous tissue.
• In oncocytomas, TIMP-3 and RASSF1A mRNA levels were significantly higher (3.2-fold and 3.8-fold, respectively), while VHL mRNA levels were significantly lower (2.2-fold) compared to healthy tissues (p < 0.05).

Conclusions:

• The precise roles of VHL, TIMP-3, and RASSF1A mRNA expression in the pathogenesis of renal tumors remain unclear.
• Additional investigations are warranted to fully elucidate the molecular mechanisms involved in renal tumor formation and progression.